Fetal Biliary Atresia: Ultrasound Clues And Outcomes
Fetal biliary atresia is an uncommon and serious cause of neonatal cholestasis in which the bile ducts become damaged or obliterated. The condition may begin before birth, although prenatal imaging often cannot provide a definite diagnosis. Careful assessment of the gallbladder, porta hepatis, liver, spleen and associated anatomy can raise suspicion and help families prepare for early postnatal investigation.
For Australian clinicians and families, the practical issue is timely referral. A pregnancy managed in a regional centre may require review by a tertiary fetal medicine service in Sydney, Melbourne, Brisbane, Perth, Adelaide or another major city. Early communication between the sonographer, obstetric team, neonatologist, paediatric gastroenterologist and liver surgeon can make the transition from an antenatal concern to definitive treatment much smoother.
| Prenatal or postnatal finding | What it may indicate | Important limitation |
|---|---|---|
| Small, absent or difficult-to-visualise gallbladder | Possible biliary atresia or gallbladder abnormality | The gallbladder can be hard to see because of fetal position, gestation or technical factors |
| Irregular or elongated gallbladder | Abnormal extrahepatic biliary development | This appearance is not specific and requires repeat assessment |
| Triangular cord sign | Fibrotic tissue at the porta hepatis | Usually assessed after birth and depends on operator experience |
| Enlarged hepatic artery | Increased arterial flow associated with biliary obstruction | Can support suspicion but cannot confirm the diagnosis |
| Splenomegaly or multiple spleens | Possible evolving liver disease or syndromic biliary atresia | May be absent in the newborn period |
| Persistent jaundice and pale stools | Neonatal cholestasis requiring urgent investigation | Clinical signs after birth are more decisive than antenatal imaging |
What Prenatal Ultrasound Can Reveal
The most frequently discussed antenatal marker is an absent, very small or abnormal gallbladder. During a systematic scan, the gallbladder should be sought in its expected position beneath the right lobe of the liver and assessed in more than one plane. A gallbladder that cannot be seen on a single examination is not enough to diagnose biliary atresia; fetal position, maternal habitus, gestational age and image quality can all create a false impression.
Other reported findings include an irregular gallbladder contour, a cystic structure near the porta hepatis, increased hepatic artery calibre and an abnormal liver texture. Splenomegaly, situs abnormalities, intestinal malrotation, congenital heart disease and polysplenia may point towards a syndromic form. The combination of multiple spleens and abnormal abdominal arrangement is particularly relevant because it can alter both prognosis and the newborn’s broader assessment.
The sensitivity of prenatal ultrasound remains limited. Many babies with biliary atresia have no convincing abnormality on routine morphology or third-trimester scans. A normal scan therefore does not exclude the condition. When concern persists, serial imaging and review by a maternal-fetal medicine specialist may be useful, especially if there are associated anomalies or a family history of an unexplained neonatal liver disorder.
Conditions That Can Mimic The Scan
A non-visualised gallbladder has a broad differential diagnosis. It may reflect gallbladder agenesis, transient contraction after fetal feeding, technical limitations or an unusual anatomical position. A cystic lesion around the porta hepatis may represent a choledochal cyst, hepatic cyst or other abdominal abnormality rather than biliary atresia. Distinguishing these possibilities requires a careful survey rather than reliance on one isolated sign.
Congenital infection is another important part of the differential. Cytomegalovirus, rubella, toxoplasmosis and other infections can contribute to fetal growth restriction, hepatosplenomegaly, abnormal liver echogenicity or neonatal cholestasis. Clinicians reviewing possible fetal liver disease may find broader context in this discussion of neonatal viral infections, while remembering that antenatal infection testing must be guided by the clinical picture and current Australian protocols.
Maternal medications and immune conditions also deserve attention. A medication history should include prescribed drugs, over-the-counter products and supplements, with a clear record of timing and dose. Pregnancies after organ transplantation may involve immunosuppressive medicines and complex specialist monitoring; relevant background is available in this overview of maternal immunosuppressive therapy. These exposures do not establish biliary atresia, but they can influence the differential diagnosis and neonatal planning.
Planning Care Before Birth
A suspected abnormality should be explained with balanced language. Families need to know that ultrasound can identify risk markers but cannot usually confirm whether the bile ducts are patent. The likely next steps include a detailed fetal assessment, review of associated anatomy, consultation with a neonatologist and a plan for checking the baby promptly after delivery.
The place of birth matters. If the scan suggests significant syndromic disease, fetal growth concerns or another major anomaly, birth at or near a tertiary perinatal centre may be appropriate. In Australia, referral pathways vary between states and territories, and a family living in regional New South Wales, northern Queensland or rural Western Australia may need coordinated travel and accommodation support. Telehealth can help with preliminary counselling, but it does not replace an examination and multidisciplinary planning where urgent surgery may be required.
Delivery timing is generally based on obstetric indications rather than biliary atresia alone. There is no established benefit to planned preterm birth for an isolated suspected biliary abnormality. The newborn team should instead prepare for early assessment of colour, feeding, abdominal examination, stool pigmentation and biochemical liver function. Parents can be shown examples of normal and pale stools, although they should receive clear written guidance rather than being expected to recognise subtle changes without support.
Confirming The Diagnosis After Delivery
Persistent jaundice in a newborn is not automatically physiological. Jaundice that continues beyond two weeks, or appears with dark urine and pale or clay-coloured stools, should prompt measurement of total and direct bilirubin. Direct hyperbilirubinaemia indicates cholestasis and requires timely investigation. Waiting for the baby to become visibly unwell can delay the pathway to treatment.
Postnatal ultrasound assesses the liver, gallbladder, bile duct region, spleen and hepatic blood flow. Features such as an abnormal or absent gallbladder, the triangular cord sign, hepatic artery enlargement and splenic abnormalities can strengthen suspicion. However, ultrasound cannot reliably distinguish every case from neonatal hepatitis, choledochal cyst or other causes of conjugated jaundice.
Blood tests commonly include liver enzymes, gamma-glutamyl transferase, clotting studies, glucose, albumin and selected metabolic, infectious and genetic investigations. A hepatobiliary scan may demonstrate impaired bile flow, though it is not definitive. Liver biopsy can provide supportive information, but operative cholangiography remains the key diagnostic procedure when biliary atresia is strongly suspected. The exact sequence is determined by the paediatric liver team and the baby’s clinical stability.
Treatment And Longer-Term Outcomes
The principal operation is the Kasai portoenterostomy, which creates a drainage pathway from the liver to the intestine using a loop of bowel. Earlier surgery generally offers a better chance of establishing bile flow, although age at operation is only one part of the outcome. A baby who undergoes the procedure before six weeks may still require transplantation, while some older infants can achieve useful drainage after surgery.
Postoperative care includes antibiotics according to local protocol, nutritional support, vitamin supplementation and close monitoring for ascending cholangitis. Growth can be affected by fat malabsorption and chronic liver disease, so dietitians and paediatric gastroenterologists are important members of the team. Regular review also checks bilirubin, liver enzymes, clotting, growth, bone health and signs of portal hypertension.
Some children live for years with their native liver after a successful Kasai procedure. Others develop recurrent cholangitis, progressive fibrosis, portal hypertension or poor growth and eventually need liver transplantation. Long-term outcomes are influenced by the anatomy of the disease, associated congenital abnormalities, the speed of diagnosis, the response to surgery and access to specialist follow-up.
The subject sits within a wider field of perinatal research involving fetal imaging, neonatal surgery, congenital infection and long-term child health. Archived scientific material from the FAOPS 2020 congress provides historical context for the type of perinatal and neonatal research discussed by specialists across Asia and Oceania, although clinical decisions should always rely on current guidelines and local expert advice.
For Australian practice, the safest response to a concerning scan is a documented referral rather than reassurance based on a single normal view of the gallbladder. Arrange appropriate fetal medicine review, alert the newborn service, and ensure that conjugated bilirubin is checked promptly if jaundice persists. Early recognition gives families clearer information and gives the paediatric liver team the best opportunity to investigate and treat biliary obstruction without avoidable delay.
